Article
The incidence of inhibitor development according to specific mutations--and treatment?
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis - 1 Jun 2003
Goodeve Anne
Abstract excerpt
The spectrum of mutations in the factor VIII (FVIII) gene was investigated in a cohort of patients with severe haemophilia A, together with the relationship between mutation type and inhibitor development DNA analysis was undertaken on 55 previously untreated patients in the Recombinate PUP mutation study who had all received the same clotting factor treatment and underwent regular monitoring for inhibitor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
